Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

When Will Johnson & Johnson Start to Profit From Its COVID Vaccine?

TheMotleyFool

0 0

When Will Johnson & Johnson Start to Profit From Its COVID Vaccine?

In this Motley Fool Live video recorded on March 26, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino discuss the coronavirus vaccine profit prospects of Johnson & Johnson (NYSE: JNJ). The company has pledged to sell the vaccine without taking a profit during the pandemic.

Source Fool.com

Like: 0

JNJ

Share